Article focuses on ISMP’s alert regarding mix-ups between the pediatric formulation of the Pfizer-BioNTech COVID-19 vaccine in children 5 to 11 years of age and the formulation for individuals 12 years of age or older.
For the full text, visit Specialty Pharmacy Continuum online. Please note that access may require free registration.
More News
ECRI’s report warns of potential safety risks with 10 health technologies, including single-use products, medication cabinets, cybersecurity of cloud-based systems, and ventilator disinfection
I knew if I wanted to become a subject matter expert and advance through the ranks of medication safety specialists, I needed to align myself with the organization considered the gold standard for medication safety information.
This article appeared on the Pharmacy Practice News website on December 15, 2022